Ma, T. M. et al. Local failure events in prostate cancer treated with radiotherapy: a pooled analysis of 18 randomized trials from the meta-analysis of randomized trials in cancer of the prostate consortium (LEVIATHAN). Eur. Urol. 82, 487–498 (2022).

Article  PubMed  Google Scholar 

Valle, L. F. et al. A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER). Eur. Urol. 80, 280–292 (2021).

Article  PubMed  Google Scholar 

Matei, D. V. et al. Salvage radical prostatectomy after external beam radiation therapy: a systematic review of current approaches. Urol. Int. 94, 373–382 (2015).

Article  PubMed  Google Scholar 

Kanthabalan, A. et al. Intraprostatic cancer recurrence following radical radiotherapy on transperineal template mapping biopsy: implications for focal ablative salvage therapy. J. Urol. 204, 950–955 (2020).

Article  CAS  PubMed  Google Scholar 

Davalos, R. V., Mir, L. M. & Rubinsky, B. Tissue ablation with irreversible electroporation. Ann. Biomed. Eng. 33, 223–231 (2005).

Article  CAS  PubMed  Google Scholar 

Blazevski, A. et al. Salvage irreversible electroporation for radio-recurrent prostate cancer – the prospective FIRE trial. BJU Int. https://doi.org/10.1111/bju.15947 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Geboers, B. et al. Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancer. BJU Int. https://doi.org/10.1111/bju.15948 (2023).

Article  PubMed  Google Scholar 

Marra, G. et al. The SAFE Pilot Trial — SAlvage Focal Irreversible Electroporation — for recurrent localized prostate cancer: rationale and study protocol. Front. Surg. https://doi.org/10.3389/fsurg.2022.900528 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Jansen, B. H. E. et al. Detection of recurrent prostate cancer using prostate-specific membrane antigen positron emission tomography in patients not meeting the Phoenix criteria for biochemical recurrence after curative radiotherapy. Eur. Urol. Oncol. 4, 821–825 (2021).

Article  PubMed  Google Scholar